o-Nitro-phenylessigsaeure-anion | 14599-61-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: o-Nitro-phenylessigsaeure-anion
• 英文别名: 2-(2-Nitrophenyl)acetate
• CAS: 14599-61-2
• 化学式: C₈H₆NO₄
• 分子量: 180.14
• InChiKey: WMUZDBZPDLHUMW-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  86
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• ENZYMATICALLY AND HYDROLYTICALLY STABLE RESINS, RESIN MONOMERS, AND RESIN COMPOSITES FOR USE IN DENTAL PREVENTIVE AND RESTORATIVE APPLICATIONS
  申请人：ADA Foundation

  公开号：US20150257986A1

  公开（公告）日：2015-09-17

  A composition of matter includes one or more functionalized vinylbenzyl components of the formula covalently connected to one or more R functional components; the one or more R functional groups selected from a group including one or more hydroxyl methyl (—CHOH—) moieties and/or derivatives thereof, one or more ethoxy (—CH 2 —CH 2 —O—) moieties and/or derivatives thereof, and one or more benzene (C 6 H 6 ) and/or derivatives thereof; and ether links that connect the functionalized vinylbenzyl components and the R functional components.

  一种物质的组成包括一个或多个功能化的乙烯苯基组分，其化学式为与一个或多个R功能组分共价连接；所述一个或多个R功能基从包括一个或多个羟甲基（—CHOH—）基团及/或其衍生物、一个或多个乙氧基（—CH2—CH2—O—）基团及/或其衍生物、一个或多个苯基（C6H6）及/或其衍生物的群组中选择；以及连接功能化的乙烯苯基组分和R功能组分的醚键。
• [EN] PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE PYRROLO[2,3-D]PYRIMIDINE CONVENANT COMME ANTAGONISTES DU RÉCEPTEUR GCRP
  申请人：GLAXO GROUP LTD

  公开号：WO2009080682A1

  公开（公告）日：2009-07-02

  The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.

  本发明涉及新型化合物，这些化合物是CGRP受体拮抗剂，涉及它们的制备方法，含有它们的组合物，以及它们在治疗偏头痛、头痛和丛集性头痛中的应用。
• [EN] AMINOMETHYL-BIARYL DERIVATIVES AS COMPLEMENT FACTOR D INHIBITORS AND USES THEREOF<br/>[FR] DÉRIVÉS D'AMINOMÉTHYL-BIARYL EN TANT QU'INHIBITEURS DU FACTEUR D DU COMPLÉMENT ET LEURS UTILISATIONS
  申请人：NOVARTIS AG

  公开号：WO2015009977A1

  公开（公告）日：2015-01-22

  The present invention provides a compound of formula (I), a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种公式(I)的化合物，一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药物活性剂的组合物和一种药物组合物。
• DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA
  申请人：The Trustees of Princeton University

  公开号：US20150266809A1

  公开（公告）日：2015-09-24

  Double caged GABA compounds and compositions including the same are described. Methods of synthesizing and using double caged GABA compounds are provided.

  描述了双笼式GABA化合物及包括其在内的组合物。提供了合成和使用双笼式GABA化合物的方法。
• Colorant compounds
  申请人：Banning H. Jeffrey

  公开号：US20060020141A1

  公开（公告）日：2006-01-26

  Compounds of the formula wherein M is either (1) a metal ion having a positive charge of +y wherein y is an integer which is at least 2, said metal ion being capable of forming a compound with at least two chromogen moieties, or (2) a metal-containing moiety capable of forming a compound with at least two chromogen moieties, z is an integer representing the number of chromogen moieties associated with the metal and is at least 2, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , a, b, c, d, Y, and z are as defined herein, Q − is a COO − group or a SO 3 — group, A is an organic anion, and CA is either a hydrogen atom or a cation associated with all but one of the Q − groups.

  式中的化合物，其中M是一个带有正电荷+y的金属离子，其中y是至少为2的整数，该金属离子能够与至少两个色团基团形成化合物，或者M是一个含金属基团的基团，能够与至少两个色团基团形成化合物，z是表示与金属相关的色团基团数量的整数，至少为2，R1、R2、R3、R4、R5、R6、R7、a、b、c、d、Y和z的定义如上所述，Q-是一个COO-基团或SO3-基团，A是一个有机阴离子，CA是一个氢原子或与除一个Q-基团之外的所有Q-基团相关联的阳离子。